The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Coronary Angiography

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Coronary Angiography


High impact information on Coronary Angiography


Chemical compound and disease context of Coronary Angiography


Biological context of Coronary Angiography


Anatomical context of Coronary Angiography


Associations of Coronary Angiography with chemical compounds

  • STUDY SELECTION: Selected articles on the effects of cholesterol reduction and lifestyle modification on angiographic coronary artery disease, on the animal models of atherosclerosis progression and regression, and on the limitations of coronary angiography [25].
  • INTERVENTIONS: After patients received saline for hydration, coronary angiography and left ventriculography were done with iopamidol (average dose, 203 +/- 56 cc) [26].
  • In this study, echocardiograms were recorded during step-wise infusion of dobutamine to a maximum dose of 30 micrograms/kg/min in 103 patients who also underwent quantitative coronary angiography [27].
  • Quantitative coronary angiography revealed that intracoronary infusion of acetylcholine resulted in a change of diameter (versus infusion of 5% dextrose in water) of +4 +/- 1% in control monkeys and -11 +/- 4% in unstable monkeys consuming a high-cholesterol diet (p less than 0.05) [28].
  • Measurements were made before and after nitroglycerin (0.4 mg, sublingual) by means of quantitative magnification coronary angiography using photospot film and a calibrated 6-power viewing device [29].

Gene context of Coronary Angiography

  • Genotyping at the GNB3 and the eNOS gene was performed on 48 individuals receiving either the alpha(1)-adrenoceptor agonist methoxamine (5 mg i.c.) and/or the alpha(2)-adrenoceptor agonist BHT 933 (5 mg i.c.). CBF was calculated from quantitative coronary angiography and intracoronary Doppler flow velocity measurement [30].
  • A new apolipoprotein A1 (APOA1) gene variant has been identified in a family ascertained through a proband undergoing coronary angiography [31].
  • This study investigated the effect of several polymorphisms [C677 T, A1298C of methylenetetrahydrofolate reductase (MTHFR) and A66G of methionine synthase reductase (MTRR) genes] on Hcy levels and DNA damage in 68 patients who underwent coronary angiography [32].
  • TP53 11951_11966dup16bp, R72P, and 13494G>A polymorphisms were characterized in a cohort of 779 patients, of whom 342 cases had developed restenosis (as defined by >50% loss of lumen compared with immediate post-procedure results) at repeat quantitative coronary angiography at six months post angioplasty [33].
  • We conclude that cardiac transplant patients with evidence of transplant coronary artery disease on coronary angiography have altered hemostatic function which is reflected by elevated levels of circulating t-PA and PAI-1 antigens [34].

Analytical, diagnostic and therapeutic context of Coronary Angiography


  1. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. Zijlstra, F., de Boer, M.J., Hoorntje, J.C., Reiffers, S., Reiber, J.H., Suryapranata, H. N. Engl. J. Med. (1993) [Pubmed]
  2. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. Kay, J., Chow, W.H., Chan, T.M., Lo, S.K., Kwok, O.H., Yip, A., Fan, K., Lee, C.H., Lam, W.F. JAMA (2003) [Pubmed]
  3. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Cannon, C.P., Gibson, C.M., McCabe, C.H., Adgey, A.A., Schweiger, M.J., Sequeira, R.F., Grollier, G., Giugliano, R.P., Frey, M., Mueller, H.S., Steingart, R.M., Weaver, W.D., Van de Werf, F., Braunwald, E. Circulation (1998) [Pubmed]
  4. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Tornvall, P., Båvenholm, P., Landou, C., de Faire, U., Hamsten, A. Circulation (1993) [Pubmed]
  5. Coronary vasomotor effects of serotonin in patients with angina. Relation to coronary stenosis morphology. Tousoulis, D., Davies, G., McFadden, E., Clarke, J., Kaski, J.C., Maseri, A. Circulation (1993) [Pubmed]
  6. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. Serruys, P.W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P. N. Engl. J. Med. (1994) [Pubmed]
  7. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. Boucher, C.A., Brewster, D.C., Darling, R.C., Okada, R.D., Strauss, H.W., Pohost, G.M. N. Engl. J. Med. (1985) [Pubmed]
  8. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. Waters, D.D., Alderman, E.L., Hsia, J., Howard, B.V., Cobb, F.R., Rogers, W.J., Ouyang, P., Thompson, P., Tardif, J.C., Higginson, L., Bittner, V., Steffes, M., Gordon, D.J., Proschan, M., Younes, N., Verter, J.I. JAMA (2002) [Pubmed]
  9. Snuff-induced hypertension in pheochromocytoma. McPhaul, M., Punzi, H.A., Sandy, A., Borganelli, M., Rude, R., Kaplan, N.M. JAMA (1984) [Pubmed]
  10. Rest-redistribution thallium-201 scintigraphy to determine myocardial viability early after myocardial infarction. Lomboy, C.T., Schulman, D.S., Grill, H.P., Flores, A.R., Orie, J.E., Granato, J.E. J. Am. Coll. Cardiol. (1995) [Pubmed]
  11. False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings. Bach, D.S., Muller, D.W., Gros, B.J., Armstrong, W.F. J. Am. Coll. Cardiol. (1994) [Pubmed]
  12. Which variable of stenosis severity best describes the significance of an isolated left anterior descending coronary artery lesion? Correlation between quantitative coronary angiography, intracoronary Doppler measurements and high dose dipyridamole echocardiography. Danzi, G.B., Pirelli, S., Mauri, L., Testa, R., Ciliberto, G.R., Massa, D., Lotto, A.A., Campolo, L., Parodi, O. J. Am. Coll. Cardiol. (1998) [Pubmed]
  13. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy. de Grooth, G.J., Zerba, K.E., Huang, S.P., Tsuchihashi, Z., Kirchgessner, T., Belder, R., Vishnupad, P., Hu, B., Klerkx, A.H., Zwinderman, A.H., Jukema, J.W., Sacks, F.M., Kastelein, J.J., Kuivenhoven, J.A. J. Am. Coll. Cardiol. (2004) [Pubmed]
  14. Effect of calcium-binding additives on ventricular fibrillation and repolarization changes during coronary angiography. Zukerman, L.S., Friehling, T.D., Wolf, N.M., Meister, S.G., Nahass, G., Kowey, P.R. J. Am. Coll. Cardiol. (1987) [Pubmed]
  15. Reflex vasodilation induced by coronary angiography in human subjects. Zelis, R., Caudill, C.C., Baggette, K., Mason, D.T. Circulation (1976) [Pubmed]
  16. Regional myocardial hemodynamic and metabolic effects of ionic and nonionic contrast media in normal and ischemic states. Gerber, K.H., Higgins, C.B., Yuh, Y.S., Koziol, J.A. Circulation (1982) [Pubmed]
  17. Left ventricular functional reserve in patients with syndrome X: evaluation by continuous ventricular function monitoring. Yoshio, H., Shimizu, M., Kita, Y., Ino, H., Taki, J., Takeda, R. J. Am. Coll. Cardiol. (1993) [Pubmed]
  18. Relation between myocardial thallium-201 kinetics during exercise and quantitative coronary angiography in patients with one vessel coronary artery disease. Hadjimiltiades, S., Watson, R., Hakki, A.H., Heo, J., Iskandrian, A.S. J. Am. Coll. Cardiol. (1989) [Pubmed]
  19. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients. Ombres, D., Pannitteri, G., Montali, A., Candeloro, A., Seccareccia, F., Campagna, F., Cantini, R., Campa, P.P., Ricci, G., Arca, M. Arterioscler. Thromb. Vasc. Biol. (1998) [Pubmed]
  20. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. Thom, D.H., Grayston, J.T., Siscovick, D.S., Wang, S.P., Weiss, N.S., Daling, J.R. JAMA (1992) [Pubmed]
  21. Evaluation of carotid artery and aortic intima-media thickness measurements for exclusion of significant coronary atherosclerosis in patients scheduled for heart valve surgery. Belhassen, L., Carville, C., Pelle, G., Monin, J.L., Teiger, E., Duval-Moulin, A.M., Dupouy, P., Dubois Rande, J.L., Gueret, P. J. Am. Coll. Cardiol. (2002) [Pubmed]
  22. Intraoperative coronary angiography using fluorescein. Takayama, T., Wanibuchi, Y., Suma, H., Terada, Y., Saito, T., Fukuda, S., Furuta, S., Minemura, T. Ann. Thorac. Surg. (1991) [Pubmed]
  23. Functional integrity and aging of the left internal thoracic artery after coronary artery bypass surgery. Amoroso, G., Tio, R.A., Mariani, M.A., Van Boven, A.J., Jessurun, G.A., Monnink, S.H., Grandjean, J.G., Boonstra, P.W., Crijns, H.J. J. Thorac. Cardiovasc. Surg. (2000) [Pubmed]
  24. A validated simple model to predict coexistent coronary disease in patients undergoing mitral valve surgery. Lim, E., Ali, A., Khalpey, Z., Ashrafian, H., Jackson, C., Ali, Z., Chamageorgakis, T., Wells, F., Pepper, J., Desouza, A., Moat, N. J. Thorac. Cardiovasc. Surg. (2005) [Pubmed]
  25. Limitations of angiography for analyzing coronary atherosclerosis progression or regression. Hong, M.K., Mintz, G.S., Popma, J.J., Kent, K.M., Pichard, A.D., Satler, L.F., Leon, M.B. Ann. Intern. Med. (1994) [Pubmed]
  26. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Davidson, C.J., Hlatky, M., Morris, K.G., Pieper, K., Skelton, T.N., Schwab, S.J., Bashore, T.M. Ann. Intern. Med. (1989) [Pubmed]
  27. Echocardiographic detection of coronary artery disease during dobutamine infusion. Sawada, S.G., Segar, D.S., Ryan, T., Brown, S.E., Dohan, A.M., Williams, R., Fineberg, N.S., Armstrong, W.F., Feigenbaum, H. Circulation (1991) [Pubmed]
  28. Psychosocial factors impair vascular responses of coronary arteries. Williams, J.K., Vita, J.A., Manuck, S.B., Selwyn, A.P., Kaplan, J.R. Circulation (1991) [Pubmed]
  29. Magnitude of dilatation of large and small coronary arteries of nitroglycerin. Feldman, R.L., Pepine, C.J., Conti, C.R. Circulation (1981) [Pubmed]
  30. Role of the eNOS Glu298Asp variant on the GNB3825T allele dependent determination of alpha-adrenergic coronary constriction. Naber, C.K., Baumgart, D., Heusch, G., Siffert, W., Oldenburg, O., Huesing, J., Erbel, R. Pharmacogenetics (2003) [Pubmed]
  31. Apolipoprotein A1 Baltimore (Arg10----Leu), a new ApoA1 variant. Ladias, J.A., Kwiterovich, P.O., Smith, H.H., Karathanasis, S.K., Antonarakis, S.E. Hum. Genet. (1990) [Pubmed]
  32. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Botto, N., Andreassi, M.G., Manfredi, S., Masetti, S., Cocci, F., Colombo, M.G., Storti, S., Rizza, A., Biagini, A. Eur. J. Hum. Genet. (2003) [Pubmed]
  33. TP53 haplotype-based analysis and incidence of post-angioplasty restenosis. Zee, R.Y., Cook, N.R., Kim, C.A., Fernandez-Cruz, A., Lindpaintner, K. Hum. Genet. (2004) [Pubmed]
  34. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients. Warshofsky, M.K., Wasserman, H.S., Wang, W., Teng, P., Sciacca, R., Apfelbaum, M., Schwartz, A., Michler, R.E., Mancini, D.M., Cannon, P.J., Rabbani, L.E. Am. J. Cardiol. (1997) [Pubmed]
  35. Precordial ST-segment depression during acute inferior myocardial infarction: clinical, scintigraphic and angiographic correlations. Gibson, R.S., Crampton, R.S., Watson, D.D., Taylor, G.J., Carabello, B.A., Holt, N.D., Beller, G.A. Circulation (1982) [Pubmed]
  36. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Zaret, B.L., Rigo, P., Wackers, F.J., Hendel, R.C., Braat, S.H., Iskandrian, A.S., Sridhara, B.S., Jain, D., Itti, R., Serafini, A.N. Circulation (1995) [Pubmed]
  37. Noninvasive and invasive demonstration of spontaneous regression of coronary artery disease. Roth, D., Kostuk, W.J. Circulation (1980) [Pubmed]
  38. Transthoracic Doppler assessment of coronary flow velocity reserve in children with Kawasaki disease: comparison with coronary angiography and thallium-201 imaging. Hiraishi, S., Hirota, H., Horiguchi, Y., Takeda, N., Fujino, N., Ogawa, N., Nakahata, Y. J. Am. Coll. Cardiol. (2002) [Pubmed]
  39. Value of lead V4R in exercise testing to predict proximal stenosis of the right coronary artery. Braat, S.H., Kingma, J.H., Brugada, P., Wellens, H.J. J. Am. Coll. Cardiol. (1985) [Pubmed]
WikiGenes - Universities